Cough-Syrup Abuse May Draw FDA Restrictions

An FDA advisory panel will meet Sept. 14 to discuss whether dextromethorphan should be a controlled substance, reviewing the common cough suppressant because of increasing signs of abuse and injuries among adolescents. Non-medical use of dextromethorphan accounted for an estimated 7,988 emergency room visits in 2008, up from 4,634 in 2004, according to a U.S. government report.